Physician profile
Alexus Goodson
NPI 1285261404
$2,549.97
in general payments reported to CMS, 2019-2025
15 companies · $566 in 2025
The $566 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $311 · 2023: $949 · 2024: $724 · 2025: $566.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,220 · Education: $18.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,219.75 |
| Education | $18.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $974.98 | 2022-2025 | |
| Pfizer INC. | $459.98 | 2023-2025 | |
| Lilly USA, LLC | $342.66 | 2022-2025 | Mounjaro, Jardiance, Zepbound |
| Novo Nordisk INC | $192.45 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $97.79 | 2022-2025 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $95.37 | 2023-2024 | |
| Glaxosmithkline, LLC. | $84.06 | 2022-2025 | Trelegy Ellipta, Shingrix |
| Biohaven Pharmaceutical Holding Company Ltd. | $71.04 | 2022 | |
| Astellas Pharma US INC | $55.69 | 2023 | Veozah, Myrbetriq |
| Astrazeneca Pharmaceuticals Lp | $46.01 | 2022-2024 | Breztri, Xigduo |
| Janssen Pharmaceuticals, INC | $41.22 | 2022-2023 | Xarelto |
| Otsuka America Pharmaceutical, INC. | $27.91 | 2024 | Rexulti |
| Insulet Corporation | $27.52 | 2023 | Omnipod |
| Merck Sharp & Dohme LLC | $18.70 | 2024 | Gardasil, Gardasil 9, Capvaxive |
| Cranial Technologies, INC | $14.59 | 2025 | Doc Band |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexus Goodson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.